Efficacy and Safety of Canagliflozin Compared With Placebo in Older Patients With Type 2 Diabetes Mellitus: A Pooled Analysis of Clinical Studies

BMC Endocrine Disorders- United Kingdom

doi 10.1186/1472-6823-14-37

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search